During this series of three webinars, an experienced group of national diabetes and endocrine experts will discuss the acute and long-term impact of COVID-19 on diabetes and endocrine conditions. It will also explore the latest research concerning whether pre-existing metabolic and endocrine diseases alter the severity of COVID-19 infections. This webinar is held in association with The Society for Endocrinology.
This first webinar will provide an update on the influence of COVID-19 on diabetes and glucocorticoid replacement. Specialists will also explore the role of androgens and underlying diabetes on patients' susceptibility to COVID-19.
Join this webinar to explore the role of diabetes mellitus in susceptibility and outcomes of COVID-19, the role of androgens on COVID-19 susceptibility and outcomes, and to understand the influence of COVID-19 on diabetes, sodium balance and glucocorticoid replacement.
This second episode will explore the influence of vitamin D, metabolism and glucocorticoid replacement and the impact of sodium balance on patient susceptibility and morbidity from the COVID-19 infection.
Join this webinar to understand the role of vitamin D metabolism in COVID outcomes, appreciate the safe management of glucocorticoid replacement in patients with COVID-19 infection, and appreciate the complex role of metabolism in COVID-19 mortality.
This webinar will provide an update on the influence of COVID on thyroid disease, as well as exploring the role of oestrogen and underlying thyroid disorders on susceptibility to COVID-19.
Join this webinar to explore the effect of COVID 19 on the thyroid gland, assess whether thyroid abnormalities impact the outcomes of COVID-19, and learn more about the role of oestrogen in COVID-19 outcomes.
A certificate of attendance and CPD certificate with 1 CPD credit(s) per webinar of this series will be issued to those joining the webinars live. Certificates of attendance for CPD will be automatically issued after 7 days, but only where a delegate watches the webinar live in its entirety.
Join in the conversation online
Follow us on Twitter: @RoySocMed